Performance of cassette-based blood gas analyzers to monitor blood glucose and lactate levels in a surgical intensive care setting

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 7, 2013, Pages 1417-1427

  Poesen, Koen ^a   De Prins, Martine ^a   Van Den Berghe, Greet ^a,b   Van Eldere, Johan ^a,b   Vanstapel, Florent ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

blood gas analyzer; glucose; lactic acid; point of care systems; tight glucose control

Indexed keywords

GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEXOKINASE; LACTATE DEHYDROGENASE; LACTIC ACID;

ANALYZER; ARTICLE; BLOOD GAS; BLOOD GLUCOSE MONITORING; COMPARATIVE STUDY; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; LACTATE BLOOD LEVEL; PATIENT MONITORING; PRIORITY JOURNAL; RADIATION DETECTOR;

ADULT; BLOOD GAS ANALYSIS; BLOOD GLUCOSE; CALIBRATION; CHILD; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; LACTIC ACID; MONITORING, PHYSIOLOGIC; POINT-OF-CARE SYSTEMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84882994489     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0848     Document Type: Article

References (40)

1. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-67.
2. Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den Heuvel I, et al. Intensive insulin therapy for patients in paediatric intensive care: A prospective, randomised controlled study. Lancet 2009;373:547-56.
3. Van den Berghe G, Schetz M, Vlasselaers D, Hermans G, Wilmer A, Bouillon R, et al. Clinical review: Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab 2009;94:3163-70.
4. Agus MS, Steil GM, Wypij D, Costello JM, Laussen PC, Langer M, et al. Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med 2012;367:1208-19.
5. Hirsch IB. Understanding low sugar from NICE-SUGAR. N Engl J Med 2012;367:1150-2.
6. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: A meta-analysis. JAMA 2008;300:933-44.
7. Scott MG, Bruns DE, Boyd JC, Sacks DB. Tight glucose control in the intensive care unit: Are glucose meters up to the task? Clin Chem 2009;55:18-20.
8. Kimberly MM, Vesper HW, Caudill SP, Ethridge SF, Archibold E, Porter KH, et al. Variability among five over-the-counter blood glucose monitors. Clin Chim Acta 2006;364:292-7. (Pubitemid 43120657)
9. Boyd JC, Bruns DE. Quality specifications for glucose meters: Assessment by simulation modeling of errors in insulin dose. Clin Chem 2001;47:209-14. (Pubitemid 32142918)
10. Boyd JC, Bruns DE. Monte Carlo simulation in establishing analytical quality requirements for clinical laboratory tests: Meeting clinical needs. Methods Enzymol 2009;467:411-33.
11. Neese JW, Duncan P, Bayse D, Robinson M, Cooper T, Stewart C. Development and evaluation of a hexokinase/glucose-6-phosphate dehydrogenase procedure for use as a national glucose comparison method. HEW Publication No. (CDC) 77-8330. Atlanta: Centers for Disease Control and Prevention, 1976.
12. Kunst A, Draeger B, Ziegenhorn J. UV-methods with hexokinase and glucose-6-phosphate dehydrogenase. In: Bergmeyer HU, Bergmeyer J, Grassl M, editors. Methods of enzymatic analysis: Volume VI: Metabolites 1: Carbohydrates. Weinheim-Deerfield Beach-Basel: Verlag Chemie, 1981:164.
13. Pelletier O, Arratoon C. Precision of glucose measurements in control sera by isotope dilution/mass spectrometry: Proposed definitive method compared with a comparison method. Clin Chem 1987;33:1397-402. (Pubitemid 18041978)
14. Noll F. L-(+) -lactate. In: Bergmeyer HU, Bergmeyer J, Grassl M, editors. Methods of enzymatic analysis: Volume VI: Metabolites 1: Carbohydrates. Weinheim-Deerfield Beach-Basel: Verlag Chemie, 1981:583.
15. Marbach EP, Weil MH. Rapid enzymatic measurement of blood lactate and pyruvate. Use and significance of metaphosphoric acid as a common precipitant. Clin Chem 1967;13:314-25.
16. Landt M. Glyceraldehyde preserves glucose concentrations in whole blood specimens. Clin Chem 2000;46:1144-9. (Pubitemid 30643317)
17. Krebs HA, Henseleit K. Untersuchungenüber die Harnstoffbildung im Tierkörper. Hoppe-Seyler's Zeitschrift fü r Physiol Chemie 1932;210:33-66.
18. Wahl HG. How accurately do we measure blood glucose levels in intensive care unit (ICU) patients? Best Pract Res Clin Anaesthesiol 2009;23:387-400.
19. Wahl P, Zinner C, Zengyuan Y, Bloch W, Mester J. Warming-up affects performance and lactate distribution between plasma and red blood cells. J Sports Sci Med 2010;9:499-507.
20. De Pinieux G, Chariot P, Ammi-Sa ï d M, Louarn F, Lejonc JL, Astier A, et al. Lipid-lowering drugs and mitochondrial function: Effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio. Br J Clin Pharmacol 1996;42:333-7. (Pubitemid 26284422)
21. DaOrazio P, Burnett RW, Fogh-Andersen N, Jacobs E, Kuwa K, Külpmann WR, et al. Approved IFCC recommendation on reporting results for blood glucose. International Federation of Clinical Chemistry and Laboratory Medicine Scientific Division. Working Group on Selective Electrodes and Point-of-Care Testing Approved IFCC recommendation on reporting results for blood glucose: International Federation of Clinical Chemistry and Laboratory Medicine Scientific Division, Working Group on Selective Electrodes and Point-of-Care Testing (IFCC-SD-WGSEPOCT). Clin Chem Lab Med 2006;44:1486-90.
22. Swaminathan R, Cockram CS. Effectiveness of sodium fluoride as a preservative of glucose in blood. Clin Chem 1989;35:315-7. (Pubitemid 19075618)
23. Seeley ES, Bowen R, Faix JD. Rapid blood separation is superior to fluoride for preventing in vitro reductions in measured blood glucose concentration. J Clin Pathol 2009;62:752-3.
24. NCCLS. Evaluation of the linearity of quantitative measurement procedure: A statistical approach; approved guideline. NCCLS document EP6-A. Wayne, PA: NCCLS, 2003.
25. NCCLS. Evaluation of the precision performance of quantitative measurement methods: Approved guideline, 2nd ed. NCCLS document EP5-A2. Wayne, PA: NCCLS, 2004.
26. Lentner C, editor. Scientific tables, 8th ed. Basel: Geigy-Ciba, 1981.
27. Davis RB, Thompson JE, Pardue HL. Characteristics of statistical parameters used to interpret least-squares results. Clin Chem 1978;24:611-20. (Pubitemid 8316543)
28. Draper N, Smith H. Applied regression analysis, 2nd ed. New York: John Wiley and sons, 1981.
29. Deming WE. Statistical adjustment of data. New York: John Wiley and sons, 1943. (republished in 1985 by Dover Publications Inc., New York).
30. Karon BS, Boyd JC, Klee GG. Glucose meter performance criteria for tight glycemic control estimated by simulation modeling. Clin Chem 2010;56:1091-7.
31. Ricos C, Alvarez V, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV, et al. Current databases on biologic variation: Pros, cons and progress. Scand J Clin Lab Invest 1999;59:491-500. (Pubitemid 30056739)
32. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003;31:359-66. (Pubitemid 36232926)
33. De Koninck AS, De Decker K, Van Bocxlaer J, Meeus P, Van Hoovels L. Analytical performance evaluation of four cartridge-type blood gas analyzers. Clin Chem Lab Med 2012;50:1083-91.
34. The Royal College of Pathologists of Australasia (RCPA). Chemical pathology quality assurance program. Available from: Http://www.rcpaqap.com.au/ chempath/gendocs/uploadedfiles/Allowable-Limits.pdf. Accessed 25 January, 2013.
35. Slater-MacLean L, Cembrowski G, Chin D, Shalapay C, Binette T, Hegadoren K, et al. Accuracy of glycemic measurements in the critically ill. Diabetes Technol Ther 2008;10:169-77. (Pubitemid 351677597)
36. Vlasselaers D, Herpe TV, Milants I, Eerdekens M, Wouters PJ, Moor BD, et al. Blood glucose measurements in arterial blood of intensive care unit patients submitted to tight glycemic control: Agreement between bedside tests. J Diabetes Sci Technol 2008;2:932-8.
37. Atkin SH, Dasmahapatra A, Jaker MA, Chorost MI, Reddy S. Fingerstick glucose determination in shock. Ann Intern Med 1991;114:1020-4.
38. Haupt A, Berg B, Paschen P, Dreyer M, Haring HU, Smedegaard J, et al. The effects of skin temperature and testing site on blood glucose measurements taken by a modern blood glucose monitoring device. Diabetes Technol Ther 2005;7:597-601. (Pubitemid 41208620)
39. US Food and Drug Administration (FDA). Review criteria assessment of portable blood glucose monitoring in vitro diagnostic devices using glucose oxidase, dehydrogenase or hexokinase methodology. Available from: Http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ ucm094134.htm. Accessed 25 January, 2013.
40. Karon BS, Scott R, Burritt MF, Santrach PJ. Comparison of lactate values between point-of-care and central laboratory analyzers. Am J Clin Pathol 2007;128:168-71. (Pubitemid 47121731)